Teresita Bellido
Concepts (500)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteocytes | 67 | 2026 | 227 | 12.840 |
Why?
| | Bone and Bones | 45 | 2024 | 501 | 6.670 |
Why?
| | Signal Transduction | 46 | 2026 | 1748 | 5.680 |
Why?
| | Osteoblasts | 56 | 2025 | 480 | 5.400 |
Why?
| | Osteogenesis | 35 | 2026 | 374 | 5.040 |
Why?
| | Receptor, Parathyroid Hormone, Type 1 | 13 | 2026 | 27 | 4.830 |
Why?
| | Bone Resorption | 30 | 2025 | 304 | 4.470 |
Why?
| | Parathyroid Hormone | 17 | 2024 | 149 | 4.090 |
Why?
| | Bone Remodeling | 23 | 2024 | 154 | 3.970 |
Why?
| | Osteoclasts | 37 | 2026 | 428 | 3.810 |
Why?
| | Glucocorticoids | 14 | 2024 | 236 | 3.680 |
Why?
| | Apoptosis | 35 | 2017 | 1139 | 3.180 |
Why?
| | Mice | 101 | 2026 | 5982 | 2.760 |
Why?
| | Animals | 130 | 2026 | 13526 | 2.670 |
Why?
| | Osteoporosis | 13 | 2024 | 159 | 2.410 |
Why?
| | Adaptor Proteins, Signal Transducing | 22 | 2024 | 202 | 2.320 |
Why?
| | RANK Ligand | 12 | 2025 | 188 | 2.190 |
Why?
| | Diphosphonates | 10 | 2024 | 92 | 2.080 |
Why?
| | Wnt Signaling Pathway | 12 | 2026 | 98 | 2.080 |
Why?
| | Receptors, Notch | 5 | 2022 | 28 | 1.960 |
Why?
| | Connexin 43 | 14 | 2017 | 25 | 1.940 |
Why?
| | Bone Morphogenetic Proteins | 10 | 2020 | 67 | 1.830 |
Why?
| | Glycoproteins | 15 | 2019 | 121 | 1.730 |
Why?
| | Mechanotransduction, Cellular | 10 | 2016 | 42 | 1.650 |
Why?
| | Antioxidants | 4 | 2020 | 264 | 1.460 |
Why?
| | beta Catenin | 8 | 2022 | 107 | 1.370 |
Why?
| | Bone Density Conservation Agents | 7 | 2024 | 75 | 1.310 |
Why?
| | Intercellular Signaling Peptides and Proteins | 17 | 2026 | 107 | 1.300 |
Why?
| | Bone Density | 24 | 2026 | 397 | 1.280 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2024 | 140 | 1.270 |
Why?
| | Mice, Inbred C57BL | 25 | 2025 | 1925 | 1.230 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 10 | 2013 | 84 | 1.180 |
Why?
| | Focal Adhesion Kinase 2 | 4 | 2024 | 15 | 1.170 |
Why?
| | Dental Cementum | 2 | 2026 | 2 | 1.130 |
Why?
| | Tooth Ankylosis | 2 | 2026 | 2 | 1.130 |
Why?
| | Mice, Knockout | 20 | 2024 | 910 | 1.080 |
Why?
| | Alveolar Bone Loss | 2 | 2024 | 8 | 1.060 |
Why?
| | Osteoporosis, Postmenopausal | 4 | 2024 | 29 | 1.030 |
Why?
| | Cells, Cultured | 30 | 2018 | 1569 | 1.020 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2017 | 47 | 0.980 |
Why?
| | Periodontium | 1 | 2026 | 2 | 0.980 |
Why?
| | Molar | 1 | 2026 | 3 | 0.980 |
Why?
| | Ankylosis | 1 | 2026 | 5 | 0.970 |
Why?
| | Teriparatide | 3 | 2024 | 10 | 0.960 |
Why?
| | Cell Differentiation | 13 | 2026 | 681 | 0.960 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2024 | 224 | 0.950 |
Why?
| | Bone Diseases | 3 | 2024 | 94 | 0.950 |
Why?
| | Parathyroid Hormone-Related Protein | 3 | 2025 | 23 | 0.930 |
Why?
| | Anoikis | 2 | 2019 | 9 | 0.870 |
Why?
| | Calcitriol | 11 | 2024 | 39 | 0.870 |
Why?
| | Diabetes Mellitus, Experimental | 3 | 2024 | 138 | 0.830 |
Why?
| | Receptors, Parathyroid Hormone | 3 | 2014 | 9 | 0.810 |
Why?
| | Mice, Transgenic | 12 | 2026 | 561 | 0.790 |
Why?
| | Aging | 7 | 2025 | 714 | 0.780 |
Why?
| | Interleukin-6 | 11 | 2026 | 272 | 0.770 |
Why?
| | Heart Diseases | 1 | 2024 | 221 | 0.720 |
Why?
| | Female | 47 | 2026 | 28782 | 0.720 |
Why?
| | Muscle Proteins | 1 | 2024 | 350 | 0.710 |
Why?
| | Humans | 69 | 2026 | 53230 | 0.690 |
Why?
| | Caveolin 1 | 3 | 2025 | 21 | 0.680 |
Why?
| | Bone Marrow | 6 | 2016 | 359 | 0.680 |
Why?
| | Cell Survival | 13 | 2019 | 600 | 0.670 |
Why?
| | Muscle, Skeletal | 2 | 2024 | 815 | 0.670 |
Why?
| | Fractures, Bone | 3 | 2023 | 106 | 0.660 |
Why?
| | Weight-Bearing | 6 | 2016 | 45 | 0.640 |
Why?
| | Cell Communication | 3 | 2022 | 73 | 0.620 |
Why?
| | Alendronate | 8 | 2015 | 24 | 0.610 |
Why?
| | Wnt Proteins | 7 | 2013 | 104 | 0.610 |
Why?
| | Estrogens | 7 | 2024 | 224 | 0.610 |
Why?
| | Mitogen-Activated Protein Kinases | 5 | 2004 | 152 | 0.600 |
Why?
| | X-Ray Microtomography | 8 | 2026 | 80 | 0.580 |
Why?
| | Stress, Mechanical | 5 | 2013 | 95 | 0.580 |
Why?
| | Gap Junctions | 3 | 2017 | 27 | 0.580 |
Why?
| | Matrix Metalloproteinase 14 | 1 | 2018 | 5 | 0.550 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2024 | 591 | 0.540 |
Why?
| | Bone Marrow Cells | 9 | 2021 | 188 | 0.520 |
Why?
| | Collagen Type I | 4 | 2015 | 83 | 0.510 |
Why?
| | Adipogenesis | 1 | 2017 | 54 | 0.510 |
Why?
| | Periodontal Ligament | 3 | 2026 | 4 | 0.500 |
Why?
| | ortho-Aminobenzoates | 1 | 2016 | 6 | 0.500 |
Why?
| | Down-Regulation | 7 | 2017 | 344 | 0.500 |
Why?
| | Muscular Atrophy | 1 | 2017 | 73 | 0.500 |
Why?
| | Fracture Healing | 1 | 2016 | 28 | 0.490 |
Why?
| | Fibroblast Growth Factors | 3 | 2017 | 52 | 0.490 |
Why?
| | Adipocytes | 1 | 2017 | 131 | 0.480 |
Why?
| | Organ Size | 7 | 2019 | 226 | 0.480 |
Why?
| | Cellular Microenvironment | 1 | 2016 | 30 | 0.470 |
Why?
| | Peptides | 4 | 2015 | 234 | 0.470 |
Why?
| | Models, Biological | 10 | 2016 | 737 | 0.470 |
Why?
| | Multiple Myeloma | 6 | 2024 | 3082 | 0.470 |
Why?
| | Male | 30 | 2026 | 27435 | 0.460 |
Why?
| | Estrogen Receptor beta | 3 | 2022 | 54 | 0.460 |
Why?
| | src-Family Kinases | 4 | 2005 | 34 | 0.460 |
Why?
| | Extracellular Matrix Proteins | 6 | 2022 | 69 | 0.450 |
Why?
| | Cell Line | 17 | 2025 | 1016 | 0.440 |
Why?
| | MAP Kinase Signaling System | 4 | 2012 | 127 | 0.430 |
Why?
| | Periosteum | 2 | 2012 | 25 | 0.430 |
Why?
| | Genetic Markers | 8 | 2020 | 104 | 0.430 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-5 | 4 | 2023 | 7 | 0.420 |
Why?
| | Endoplasmic Reticulum | 1 | 2014 | 99 | 0.420 |
Why?
| | Up-Regulation | 8 | 2026 | 456 | 0.420 |
Why?
| | Gene Deletion | 7 | 2019 | 279 | 0.420 |
Why?
| | Disease Models, Animal | 9 | 2026 | 1517 | 0.410 |
Why?
| | Periodontitis | 2 | 2024 | 11 | 0.410 |
Why?
| | Hematopoietic Stem Cells | 2 | 2012 | 189 | 0.410 |
Why?
| | Phosphorylation | 12 | 2014 | 533 | 0.390 |
Why?
| | Muscles | 5 | 1993 | 110 | 0.380 |
Why?
| | Phosphates | 5 | 2016 | 51 | 0.370 |
Why?
| | RNA, Messenger | 8 | 2017 | 1133 | 0.370 |
Why?
| | Enzyme Inhibitors | 6 | 2014 | 371 | 0.360 |
Why?
| | Hyperostosis | 2 | 2022 | 4 | 0.350 |
Why?
| | Gene Expression Regulation | 8 | 2017 | 1003 | 0.340 |
Why?
| | Phosphoproteins | 3 | 2018 | 117 | 0.340 |
Why?
| | Gene Expression | 5 | 2017 | 618 | 0.330 |
Why?
| | Enzyme Activation | 9 | 2010 | 267 | 0.330 |
Why?
| | Receptors, Calcitriol | 4 | 2024 | 21 | 0.330 |
Why?
| | Transcription Factors | 5 | 2024 | 571 | 0.320 |
Why?
| | Estrogen Receptor alpha | 3 | 2022 | 85 | 0.310 |
Why?
| | Receptors, Estrogen | 7 | 2022 | 134 | 0.300 |
Why?
| | Focal Adhesion Kinase 1 | 2 | 2007 | 14 | 0.300 |
Why?
| | Cytokines | 7 | 2014 | 627 | 0.290 |
Why?
| | MicroRNAs | 3 | 2019 | 397 | 0.290 |
Why?
| | Cell Membrane | 2 | 2007 | 233 | 0.290 |
Why?
| | Monocytes | 1 | 2008 | 126 | 0.260 |
Why?
| | HMGB1 Protein | 2 | 2024 | 22 | 0.250 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2024 | 141 | 0.250 |
Why?
| | Osteolysis | 3 | 2022 | 74 | 0.250 |
Why?
| | Membrane Glycoproteins | 5 | 2003 | 238 | 0.250 |
Why?
| | Protein-Tyrosine Kinases | 3 | 2010 | 87 | 0.240 |
Why?
| | Osteoprotegerin | 2 | 2016 | 53 | 0.240 |
Why?
| | Weightlessness | 1 | 2006 | 13 | 0.240 |
Why?
| | Transforming Growth Factor beta | 3 | 2025 | 136 | 0.240 |
Why?
| | Dexamethasone | 7 | 2017 | 429 | 0.240 |
Why?
| | Presenilin-1 | 1 | 2026 | 10 | 0.240 |
Why?
| | HeLa Cells | 10 | 2017 | 243 | 0.240 |
Why?
| | Calcifediol | 4 | 1991 | 8 | 0.230 |
Why?
| | Antibodies, Neutralizing | 2 | 2024 | 78 | 0.230 |
Why?
| | Caspases | 3 | 2006 | 101 | 0.230 |
Why?
| | Cell Nucleus | 5 | 2013 | 187 | 0.230 |
Why?
| | Integrins | 1 | 2005 | 34 | 0.230 |
Why?
| | SKP Cullin F-Box Protein Ligases | 1 | 2024 | 15 | 0.220 |
Why?
| | Chemokine CCL3 | 1 | 2024 | 12 | 0.220 |
Why?
| | Calcium | 6 | 2025 | 373 | 0.220 |
Why?
| | Skull | 5 | 2015 | 75 | 0.220 |
Why?
| | Ovariectomy | 6 | 2024 | 114 | 0.220 |
Why?
| | Hormone Replacement Therapy | 1 | 2004 | 21 | 0.220 |
Why?
| | Periodontal Diseases | 1 | 2024 | 12 | 0.210 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 42 | 0.210 |
Why?
| | Caspase 3 | 5 | 2017 | 92 | 0.210 |
Why?
| | Estradiol | 9 | 2007 | 215 | 0.210 |
Why?
| | Rats | 9 | 2014 | 3162 | 0.210 |
Why?
| | Muscular Diseases | 1 | 2024 | 64 | 0.210 |
Why?
| | Mutation | 6 | 2026 | 1337 | 0.210 |
Why?
| | Phenotype | 4 | 2026 | 803 | 0.210 |
Why?
| | Glucose | 1 | 2026 | 361 | 0.200 |
Why?
| | Antigens, CD | 4 | 2000 | 217 | 0.200 |
Why?
| | Multienzyme Complexes | 1 | 2003 | 42 | 0.200 |
Why?
| | Calcium Channels | 2 | 2001 | 38 | 0.200 |
Why?
| | Cysteine Endopeptidases | 1 | 2003 | 64 | 0.200 |
Why?
| | Kinetics | 8 | 2004 | 607 | 0.200 |
Why?
| | Gingivitis | 1 | 2023 | 1 | 0.200 |
Why?
| | Actins | 2 | 2005 | 114 | 0.200 |
Why?
| | Macrophages | 1 | 2026 | 380 | 0.190 |
Why?
| | Protein Kinases | 2 | 2014 | 72 | 0.190 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2016 | 392 | 0.190 |
Why?
| | Bone Diseases, Metabolic | 1 | 2023 | 79 | 0.190 |
Why?
| | Tuberous Sclerosis | 1 | 2022 | 38 | 0.190 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2024 | 868 | 0.180 |
Why?
| | Absorptiometry, Photon | 3 | 2023 | 160 | 0.180 |
Why?
| | Transfection | 6 | 2007 | 359 | 0.180 |
Why?
| | Transcription, Genetic | 8 | 2006 | 374 | 0.180 |
Why?
| | Tumor Suppressor Proteins | 1 | 2022 | 130 | 0.180 |
Why?
| | Phosphotyrosine | 2 | 1999 | 6 | 0.180 |
Why?
| | Alzheimer Disease | 1 | 2026 | 338 | 0.180 |
Why?
| | Dihydrotestosterone | 4 | 2006 | 14 | 0.180 |
Why?
| | Bone Matrix | 2 | 2019 | 16 | 0.180 |
Why?
| | Neoplasm Proteins | 1 | 2003 | 330 | 0.170 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 3 | 2025 | 46 | 0.170 |
Why?
| | Receptors, Androgen | 3 | 2006 | 48 | 0.170 |
Why?
| | Cell Division | 6 | 2005 | 289 | 0.170 |
Why?
| | Osteocalcin | 4 | 2025 | 45 | 0.170 |
Why?
| | Trans-Activators | 3 | 2018 | 139 | 0.160 |
Why?
| | Diabetes Mellitus | 1 | 2024 | 321 | 0.160 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2021 | 1367 | 0.160 |
Why?
| | DNA-Binding Proteins | 3 | 2003 | 423 | 0.160 |
Why?
| | Sex Characteristics | 2 | 2023 | 204 | 0.160 |
Why?
| | Cell Proliferation | 2 | 2016 | 1031 | 0.160 |
Why?
| | Phylogeny | 1 | 2020 | 231 | 0.160 |
Why?
| | Dentin | 1 | 2019 | 7 | 0.160 |
Why?
| | Calcitonin | 1 | 1999 | 30 | 0.160 |
Why?
| | Lymphokines | 2 | 1997 | 20 | 0.150 |
Why?
| | Growth Inhibitors | 2 | 1997 | 26 | 0.150 |
Why?
| | Protein Binding | 4 | 2011 | 670 | 0.150 |
Why?
| | Receptors, Interleukin-17 | 1 | 2018 | 2 | 0.150 |
Why?
| | Gonadal Steroid Hormones | 3 | 2007 | 39 | 0.150 |
Why?
| | Anabolic Agents | 1 | 2019 | 41 | 0.140 |
Why?
| | Tretinoin | 1 | 1999 | 53 | 0.140 |
Why?
| | Cyclins | 1 | 1998 | 38 | 0.140 |
Why?
| | Mefloquine | 1 | 2018 | 5 | 0.140 |
Why?
| | Oxidative Stress | 2 | 2017 | 819 | 0.140 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2019 | 579 | 0.140 |
Why?
| | Primary Cell Culture | 2 | 2017 | 62 | 0.140 |
Why?
| | Repressor Proteins | 1 | 2019 | 149 | 0.140 |
Why?
| | Chick Embryo | 6 | 2001 | 79 | 0.130 |
Why?
| | Femur | 2 | 2015 | 133 | 0.130 |
Why?
| | Culture Media, Conditioned | 3 | 2023 | 49 | 0.130 |
Why?
| | Bone Development | 1 | 2018 | 68 | 0.130 |
Why?
| | Nuclear Respiratory Factor 1 | 1 | 2017 | 2 | 0.130 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2017 | 10 | 0.130 |
Why?
| | Glucuronidase | 1 | 2017 | 47 | 0.130 |
Why?
| | Mice, 129 Strain | 1 | 2017 | 37 | 0.130 |
Why?
| | Osteoporotic Fractures | 1 | 2017 | 11 | 0.130 |
Why?
| | Hyponatremia | 1 | 2017 | 13 | 0.130 |
Why?
| | Gene Regulatory Networks | 1 | 2018 | 112 | 0.130 |
Why?
| | Immunohistochemistry | 3 | 2017 | 975 | 0.130 |
Why?
| | Diet | 1 | 2020 | 610 | 0.120 |
Why?
| | Infant, Newborn | 1 | 2024 | 2913 | 0.120 |
Why?
| | Hypophosphatemia, Familial | 1 | 2016 | 1 | 0.120 |
Why?
| | Random Allocation | 1 | 2017 | 284 | 0.120 |
Why?
| | Cyclin D1 | 1 | 2016 | 59 | 0.120 |
Why?
| | Etoposide | 4 | 2005 | 71 | 0.120 |
Why?
| | Receptors, Interleukin | 1 | 1996 | 10 | 0.120 |
Why?
| | Receptors, Nerve Growth Factor | 1 | 1996 | 6 | 0.120 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 2 | 2007 | 71 | 0.120 |
Why?
| | Receptors, Cytokine | 1 | 1996 | 11 | 0.120 |
Why?
| | Integrases | 2 | 2022 | 44 | 0.120 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 2 | 2010 | 17 | 0.120 |
Why?
| | Peptide Fragments | 3 | 2015 | 209 | 0.120 |
Why?
| | Time Factors | 7 | 2015 | 2991 | 0.120 |
Why?
| | Protein Structure, Tertiary | 4 | 2015 | 252 | 0.120 |
Why?
| | Hematopoiesis | 2 | 2014 | 69 | 0.120 |
Why?
| | Hindlimb Suspension | 1 | 2015 | 37 | 0.110 |
Why?
| | Promoter Regions, Genetic | 3 | 2008 | 465 | 0.110 |
Why?
| | Estrenes | 3 | 2006 | 11 | 0.110 |
Why?
| | Hindlimb | 1 | 2015 | 33 | 0.110 |
Why?
| | Adiposity | 1 | 2016 | 147 | 0.110 |
Why?
| | Homeostasis | 2 | 2012 | 209 | 0.110 |
Why?
| | Mutation, Missense | 1 | 2015 | 110 | 0.110 |
Why?
| | Testosterone | 1 | 1995 | 142 | 0.110 |
Why?
| | Enzyme Activators | 1 | 2014 | 8 | 0.110 |
Why?
| | Protein Kinase C | 2 | 2003 | 68 | 0.110 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2005 | 148 | 0.110 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 2 | 2005 | 15 | 0.110 |
Why?
| | Sirtuin 1 | 1 | 2014 | 29 | 0.110 |
Why?
| | Organ Culture Techniques | 1 | 2014 | 44 | 0.110 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2014 | 15 | 0.110 |
Why?
| | Lymphoid Tissue | 1 | 1994 | 22 | 0.110 |
Why?
| | Myeloproliferative Disorders | 1 | 2014 | 31 | 0.110 |
Why?
| | LDL-Receptor Related Proteins | 2 | 2011 | 7 | 0.100 |
Why?
| | Blotting, Western | 5 | 2011 | 587 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2014 | 147 | 0.100 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2014 | 61 | 0.100 |
Why?
| | Receptors, Steroid | 1 | 1993 | 20 | 0.100 |
Why?
| | Injections, Subcutaneous | 1 | 2013 | 55 | 0.100 |
Why?
| | Transcriptome | 1 | 2016 | 367 | 0.100 |
Why?
| | Flow Cytometry | 2 | 2012 | 400 | 0.100 |
Why?
| | TCF Transcription Factors | 1 | 2013 | 11 | 0.100 |
Why?
| | Receptor Cross-Talk | 1 | 2013 | 7 | 0.100 |
Why?
| | Cell Line, Tumor | 3 | 2024 | 1470 | 0.100 |
Why?
| | Hematologic Neoplasms | 1 | 2014 | 101 | 0.100 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 109 | 0.100 |
Why?
| | Flavonoids | 1 | 2013 | 55 | 0.090 |
Why?
| | Ulna | 2 | 2013 | 13 | 0.090 |
Why?
| | Protein Transport | 1 | 2013 | 168 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 214 | 0.090 |
Why?
| | Arrestins | 1 | 2011 | 1 | 0.090 |
Why?
| | Immunoenzyme Techniques | 1 | 2012 | 134 | 0.090 |
Why?
| | Ligands | 3 | 2007 | 203 | 0.090 |
Why?
| | Societies, Scientific | 1 | 2011 | 14 | 0.090 |
Why?
| | Transgenes | 1 | 2011 | 55 | 0.090 |
Why?
| | Health | 1 | 2011 | 21 | 0.090 |
Why?
| | Minerals | 1 | 2011 | 26 | 0.090 |
Why?
| | Fluorescent Dyes | 2 | 2023 | 90 | 0.090 |
Why?
| | Absorption | 1 | 2011 | 21 | 0.090 |
Why?
| | Lumbar Vertebrae | 2 | 2018 | 101 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2017 | 171 | 0.090 |
Why?
| | Etidronic Acid | 2 | 2001 | 4 | 0.080 |
Why?
| | Cytokine Receptor gp130 | 4 | 2000 | 13 | 0.080 |
Why?
| | Fibroblasts | 3 | 2001 | 363 | 0.080 |
Why?
| | Inflammation | 2 | 2026 | 652 | 0.080 |
Why?
| | Estrogen Antagonists | 2 | 2007 | 21 | 0.080 |
Why?
| | Spine | 1 | 2010 | 87 | 0.080 |
Why?
| | Extracellular Matrix | 1 | 2010 | 116 | 0.080 |
Why?
| | Hormones | 2 | 2008 | 58 | 0.070 |
Why?
| | Dactinomycin | 2 | 2003 | 24 | 0.070 |
Why?
| | Green Fluorescent Proteins | 3 | 2005 | 85 | 0.070 |
Why?
| | Gene Silencing | 1 | 2008 | 122 | 0.070 |
Why?
| | Biomedical Research | 1 | 2011 | 267 | 0.070 |
Why?
| | Molecular Structure | 2 | 2006 | 320 | 0.070 |
Why?
| | Nifedipine | 2 | 2001 | 24 | 0.070 |
Why?
| | Base Sequence | 4 | 1998 | 620 | 0.070 |
Why?
| | Stem Cells | 2 | 2006 | 189 | 0.070 |
Why?
| | Phospholipids | 1 | 1987 | 59 | 0.070 |
Why?
| | Cattle | 1 | 2008 | 207 | 0.070 |
Why?
| | Tibia | 1 | 2007 | 118 | 0.070 |
Why?
| | Dihydroxycholecalciferols | 1 | 1987 | 2 | 0.070 |
Why?
| | Genotype | 1 | 2008 | 563 | 0.060 |
Why?
| | bcl-Associated Death Protein | 2 | 2003 | 9 | 0.060 |
Why?
| | Weight Gain | 1 | 2008 | 245 | 0.060 |
Why?
| | Membrane Proteins | 1 | 1989 | 333 | 0.060 |
Why?
| | Spleen | 1 | 2008 | 166 | 0.060 |
Why?
| | Leukemia Inhibitory Factor | 2 | 1997 | 12 | 0.060 |
Why?
| | Fatty Acids | 1 | 1987 | 154 | 0.060 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2004 | 50 | 0.060 |
Why?
| | Antibodies, Monoclonal | 2 | 2023 | 477 | 0.060 |
Why?
| | Kidney | 1 | 2011 | 715 | 0.060 |
Why?
| | Cell Count | 1 | 2006 | 141 | 0.060 |
Why?
| | Disease Progression | 2 | 2021 | 880 | 0.060 |
Why?
| | RNA | 2 | 2005 | 173 | 0.060 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2026 | 23 | 0.060 |
Why?
| | Membrane Microdomains | 1 | 2025 | 11 | 0.060 |
Why?
| | Injections | 1 | 2005 | 59 | 0.060 |
Why?
| | Caveolae | 1 | 2005 | 5 | 0.060 |
Why?
| | Physical Stimulation | 1 | 2005 | 30 | 0.060 |
Why?
| | beta-Cyclodextrins | 1 | 2005 | 15 | 0.060 |
Why?
| | Tubulin | 1 | 2005 | 22 | 0.060 |
Why?
| | Cytoskeleton | 1 | 2005 | 39 | 0.060 |
Why?
| | src Homology Domains | 2 | 2001 | 6 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2005 | 34 | 0.060 |
Why?
| | Cyclic AMP | 1 | 2025 | 91 | 0.060 |
Why?
| | Cycloheximide | 3 | 2005 | 33 | 0.060 |
Why?
| | Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2004 | 7 | 0.060 |
Why?
| | Carrier Proteins | 2 | 2003 | 315 | 0.060 |
Why?
| | Amides | 1 | 2024 | 36 | 0.050 |
Why?
| | Drug Administration Schedule | 1 | 2005 | 370 | 0.050 |
Why?
| | Binding Sites | 3 | 2012 | 373 | 0.050 |
Why?
| | Drug Synergism | 1 | 2004 | 147 | 0.050 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2005 | 180 | 0.050 |
Why?
| | Receptors, Interleukin-6 | 3 | 2000 | 22 | 0.050 |
Why?
| | Carcinogens | 1 | 2005 | 194 | 0.050 |
Why?
| | Receptor Activator of Nuclear Factor-kappa B | 1 | 2003 | 33 | 0.050 |
Why?
| | Nuclear Matrix-Associated Proteins | 1 | 2023 | 2 | 0.050 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 34 | 0.050 |
Why?
| | DNA | 3 | 2005 | 535 | 0.050 |
Why?
| | Administration, Oral | 1 | 2024 | 456 | 0.050 |
Why?
| | CD40 Ligand | 1 | 2003 | 14 | 0.050 |
Why?
| | NF-kappa B | 2 | 2014 | 327 | 0.050 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2023 | 1 | 0.050 |
Why?
| | Prednisolone | 2 | 2002 | 56 | 0.050 |
Why?
| | Models, Genetic | 1 | 2003 | 169 | 0.050 |
Why?
| | Alveolar Process | 1 | 2023 | 6 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 128 | 0.050 |
Why?
| | Protein Kinase Inhibitors | 1 | 2024 | 233 | 0.050 |
Why?
| | Homeodomain Proteins | 1 | 2022 | 81 | 0.050 |
Why?
| | Tumor Cells, Cultured | 2 | 2002 | 441 | 0.050 |
Why?
| | Embryo, Mammalian | 1 | 2001 | 71 | 0.040 |
Why?
| | Luminescent Proteins | 1 | 2001 | 48 | 0.040 |
Why?
| | Clodronic Acid | 1 | 2021 | 19 | 0.040 |
Why?
| | Calcium Channel Blockers | 1 | 2001 | 57 | 0.040 |
Why?
| | Body Weight | 2 | 2019 | 524 | 0.040 |
Why?
| | Models, Animal | 2 | 2013 | 233 | 0.040 |
Why?
| | STAT3 Transcription Factor | 2 | 2000 | 89 | 0.040 |
Why?
| | Biotinylation | 1 | 2001 | 28 | 0.040 |
Why?
| | Isoquinolines | 1 | 2001 | 22 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2021 | 228 | 0.040 |
Why?
| | Interleukin-5 | 1 | 2000 | 6 | 0.040 |
Why?
| | Cell-Free System | 1 | 2000 | 9 | 0.040 |
Why?
| | Orchiectomy | 2 | 2002 | 38 | 0.040 |
Why?
| | Recombinant Proteins | 2 | 1998 | 489 | 0.040 |
Why?
| | Odontogenesis | 1 | 2019 | 1 | 0.040 |
Why?
| | Odontoblasts | 1 | 2019 | 4 | 0.040 |
Why?
| | Dental Pulp | 1 | 2019 | 3 | 0.040 |
Why?
| | In Situ Nick-End Labeling | 1 | 1999 | 54 | 0.040 |
Why?
| | Semaphorins | 1 | 2019 | 5 | 0.040 |
Why?
| | Rifabutin | 1 | 1999 | 5 | 0.040 |
Why?
| | Quinones | 1 | 1999 | 9 | 0.040 |
Why?
| | Lactams, Macrocyclic | 1 | 1999 | 19 | 0.040 |
Why?
| | Isotretinoin | 1 | 1999 | 8 | 0.040 |
Why?
| | Benzoquinones | 1 | 1999 | 33 | 0.040 |
Why?
| | Transcription Factor AP-1 | 1 | 2019 | 62 | 0.040 |
Why?
| | Sodium | 2 | 1991 | 89 | 0.040 |
Why?
| | Biological Transport | 2 | 1991 | 150 | 0.040 |
Why?
| | Tooth Eruption | 1 | 2018 | 2 | 0.040 |
Why?
| | Mice, Mutant Strains | 2 | 2015 | 69 | 0.040 |
Why?
| | Cell Adhesion Molecules | 1 | 1999 | 88 | 0.040 |
Why?
| | Interleukin-17 | 1 | 2018 | 34 | 0.040 |
Why?
| | Cytoplasm | 3 | 2004 | 93 | 0.040 |
Why?
| | Hyperparathyroidism, Primary | 1 | 2018 | 35 | 0.040 |
Why?
| | Oligonucleotides, Antisense | 1 | 1998 | 29 | 0.040 |
Why?
| | Molecular Sequence Data | 3 | 1995 | 759 | 0.040 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1998 | 68 | 0.040 |
Why?
| | Growth Substances | 1 | 1998 | 22 | 0.040 |
Why?
| | Connective Tissue Cells | 1 | 1997 | 1 | 0.030 |
Why?
| | Ciliary Neurotrophic Factor | 1 | 1997 | 8 | 0.030 |
Why?
| | Analysis of Variance | 1 | 1999 | 547 | 0.030 |
Why?
| | Endometrial Neoplasms | 1 | 1999 | 143 | 0.030 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 33 | 0.030 |
Why?
| | Osteogenesis Imperfecta | 1 | 2018 | 37 | 0.030 |
Why?
| | STAT1 Transcription Factor | 1 | 1997 | 28 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 3 | 2005 | 150 | 0.030 |
Why?
| | Genetic Complementation Test | 1 | 2017 | 42 | 0.030 |
Why?
| | Alkaline Phosphatase | 1 | 1997 | 92 | 0.030 |
Why?
| | Lymphocyte Activation | 2 | 1995 | 163 | 0.030 |
Why?
| | PTEN Phosphohydrolase | 1 | 2017 | 55 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2018 | 170 | 0.030 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 1998 | 228 | 0.030 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 1994 | 45 | 0.030 |
Why?
| | Receptor, Ciliary Neurotrophic Factor | 1 | 1996 | 1 | 0.030 |
Why?
| | Receptors, Interleukin-11 | 1 | 1996 | 1 | 0.030 |
Why?
| | Interleukin-11 Receptor alpha Subunit | 1 | 1996 | 1 | 0.030 |
Why?
| | Receptors, OSM-LIF | 1 | 1996 | 2 | 0.030 |
Why?
| | Receptors, Oncostatin M | 1 | 1996 | 2 | 0.030 |
Why?
| | Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 1996 | 2 | 0.030 |
Why?
| | Gait | 1 | 2017 | 90 | 0.030 |
Why?
| | Biological Assay | 1 | 1996 | 46 | 0.030 |
Why?
| | Gene Knock-In Techniques | 1 | 2015 | 22 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 1997 | 193 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2015 | 79 | 0.030 |
Why?
| | Genetic Loci | 1 | 2015 | 48 | 0.030 |
Why?
| | X-Rays | 1 | 2015 | 55 | 0.030 |
Why?
| | Accidental Falls | 1 | 2017 | 107 | 0.030 |
Why?
| | Adenocarcinoma | 1 | 1999 | 405 | 0.030 |
Why?
| | Lymphocytes | 1 | 1995 | 146 | 0.030 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2015 | 187 | 0.030 |
Why?
| | Epigenetic Repression | 1 | 2014 | 1 | 0.030 |
Why?
| | Steroids | 1 | 1995 | 61 | 0.030 |
Why?
| | Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2014 | 2 | 0.030 |
Why?
| | Stem Cell Niche | 1 | 2014 | 13 | 0.030 |
Why?
| | Androgens | 2 | 2007 | 70 | 0.030 |
Why?
| | Antigens, Differentiation | 1 | 2014 | 16 | 0.030 |
Why?
| | Adjuvants, Immunologic | 1 | 1994 | 52 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2014 | 115 | 0.030 |
Why?
| | Plasmids | 2 | 2004 | 164 | 0.030 |
Why?
| | Bucladesine | 1 | 1993 | 5 | 0.020 |
Why?
| | Diglycerides | 1 | 1993 | 10 | 0.020 |
Why?
| | Algorithms | 1 | 2017 | 667 | 0.020 |
Why?
| | Staurosporine | 1 | 1993 | 10 | 0.020 |
Why?
| | 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1993 | 9 | 0.020 |
Why?
| | Body Composition | 1 | 2015 | 355 | 0.020 |
Why?
| | Alkaloids | 1 | 1993 | 34 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 1993 | 452 | 0.020 |
Why?
| | Haversian System | 1 | 2012 | 1 | 0.020 |
Why?
| | Vanadates | 1 | 2012 | 7 | 0.020 |
Why?
| | Heart | 1 | 1994 | 350 | 0.020 |
Why?
| | Risk Assessment | 1 | 2017 | 1368 | 0.020 |
Why?
| | Binding, Competitive | 1 | 2012 | 89 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2011 | 56 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2012 | 174 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2011 | 75 | 0.020 |
Why?
| | Ion Channels | 1 | 2012 | 70 | 0.020 |
Why?
| | Phosphorus Radioisotopes | 1 | 1991 | 7 | 0.020 |
Why?
| | Spectrometry, X-Ray Emission | 1 | 2011 | 7 | 0.020 |
Why?
| | Rats, Long-Evans | 1 | 2011 | 23 | 0.020 |
Why?
| | Cholecalciferol | 1 | 1991 | 22 | 0.020 |
Why?
| | Rabbits | 1 | 2012 | 372 | 0.020 |
Why?
| | Microscopy, Electron | 1 | 2011 | 63 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2011 | 181 | 0.020 |
Why?
| | Spectrum Analysis, Raman | 1 | 2011 | 42 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2011 | 99 | 0.020 |
Why?
| | Motor Activity | 1 | 2011 | 227 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2014 | 1544 | 0.020 |
Why?
| | Physical Exertion | 1 | 2009 | 45 | 0.020 |
Why?
| | Leucine | 1 | 1989 | 114 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2017 | 1232 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2011 | 533 | 0.020 |
Why?
| | Risk Factors | 1 | 2017 | 4017 | 0.020 |
Why?
| | Rats, Inbred Lew | 1 | 2007 | 48 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2007 | 69 | 0.020 |
Why?
| | Weightlessness Simulation | 1 | 2007 | 22 | 0.020 |
Why?
| | 24,25-Dihydroxyvitamin D 3 | 1 | 1987 | 3 | 0.020 |
Why?
| | Smad Proteins | 1 | 2006 | 16 | 0.020 |
Why?
| | Response Elements | 1 | 2006 | 29 | 0.020 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2006 | 48 | 0.020 |
Why?
| | Vitamin D Deficiency | 1 | 1987 | 46 | 0.020 |
Why?
| | Chickens | 1 | 1987 | 106 | 0.020 |
Why?
| | Wnt3 Protein | 1 | 2005 | 7 | 0.010 |
Why?
| | Culture Media, Serum-Free | 1 | 2005 | 11 | 0.010 |
Why?
| | Wnt1 Protein | 1 | 2005 | 10 | 0.010 |
Why?
| | Wnt3A Protein | 1 | 2005 | 12 | 0.010 |
Why?
| | Culture Media | 1 | 2005 | 97 | 0.010 |
Why?
| | MAP Kinase Kinase 4 | 1 | 2005 | 30 | 0.010 |
Why?
| | Cholera Toxin | 1 | 2004 | 15 | 0.010 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2004 | 35 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 47 | 0.010 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2004 | 39 | 0.010 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2003 | 12 | 0.010 |
Why?
| | Caspase Inhibitors | 1 | 2003 | 16 | 0.010 |
Why?
| | Tensile Strength | 1 | 2003 | 31 | 0.010 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 2003 | 5 | 0.010 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 1 | 2003 | 5 | 0.010 |
Why?
| | Phosphotransferases | 1 | 2003 | 18 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2003 | 60 | 0.010 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2003 | 23 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2003 | 87 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2003 | 76 | 0.010 |
Why?
| | Compressive Strength | 1 | 2002 | 12 | 0.010 |
Why?
| | Seminal Vesicles | 1 | 2002 | 13 | 0.010 |
Why?
| | Uterus | 1 | 2002 | 81 | 0.010 |
Why?
| | Pyrazoles | 1 | 2002 | 123 | 0.010 |
Why?
| | Oncostatin M | 1 | 2000 | 5 | 0.010 |
Why?
| | 3T3 Cells | 1 | 2000 | 57 | 0.010 |
Why?
| | Transcriptional Activation | 1 | 2001 | 128 | 0.010 |
Why?
| | Sex Factors | 1 | 2001 | 747 | 0.010 |
Why?
| | Stromal Cells | 1 | 1997 | 77 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-rel | 1 | 1995 | 5 | 0.010 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1995 | 27 | 0.010 |
Why?
| | Chloramphenicol O-Acetyltransferase | 1 | 1994 | 8 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 2002 | 1222 | 0.010 |
Why?
| | Myocardium | 1 | 1994 | 471 | 0.010 |
Why?
| | Adult | 1 | 1995 | 14534 | 0.000 |
Why?
|
|
Bellido's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|